ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Scheme : NHMRC Project Grants
Research Topic : antimalarials
Clear All
Filter by Field of Research
Medical and Health Sciences (4)
Humoural immunology and immunochemistry (2)
Medical Parasitology (2)
Biochemistry and Cell Biology not elsewhere classified (1)
Dental therapeutics pharmacology and toxicology (1)
Medical biochemistry and metabolomics not elsewhere classified (1)
Membrane Biology (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (14)
Filter by Status
Closed (14)
Filter by Scheme
NHMRC Project Grants (14)
Filter by Country
Australia (2)
Filter by Australian State/Territory
VIC (2)
  • Researchers (0)
  • Funded Activities (14)
  • Organisations (0)
  • Funded Activity

    Pharmacokinetics And Efficacy Of Dihydroartemisinin And Artesunate Alone And In Combination Therapy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $186,740.00
    More information
    Funded Activity

    Antimalarial Properties Of Clotrimazole And Other Imidazoles

    Funder
    National Health and Medical Research Council
    Funding Amount
    $183,179.00
    More information
    Funded Activity

    The Quinoline Antimalarials: Mechanisms Of Action And Resistance In Plasmodium Falciparum

    Funder
    National Health and Medical Research Council
    Funding Amount
    $332,114.00
    More information
    Funded Activity

    L-Nucleosides: Exploitation Of Membrane Transport In The Development Of New Antimalarials.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $781,615.00
    More information
    Funded Activity

    Antimalarial Drugs - Mechanisms Of Action And Resistanc E

    Funder
    National Health and Medical Research Council
    Funding Amount
    $141,185.00
    More information
    Funded Activity

    Transport Of Amino Acids And Polyamines In The Malaria Parasite

    Funder
    National Health and Medical Research Council
    Funding Amount
    $415,631.00
    Summary
    Malaria is one of the major infectious diseases challenging the world today. There is no effective vaccine, and the malaria parasite has developed resistance to most of the antimalarial drugs that we presently have available. This work focuses on the molecular mechanisms by which the malaria parasite takes up particular classes of nutrients from the surrounding environment. It paves the way for the exploitation of these mechanisms as new and much-needed antimalarial drug targets.
    More information
    Funded Activity

    Ion Transport In The Malaria Parasite, Plasmodium Falciparum

    Funder
    National Health and Medical Research Council
    Funding Amount
    $225,721.00
    Summary
    Malaria is an infectious disease caused by single-cell protozoan parasites which, during the course of their complex lifecycle, invade the red blood cells of their human hosts. In recent years the emergence and spread of malaria parasites with high levels of antimalarial drug resistance has given rise to the very real possibility that within a few years, there will be large parts of the world in which malaria is an untreatable disease. There is therefore an urgent need for new antimalarial drugs .... Malaria is an infectious disease caused by single-cell protozoan parasites which, during the course of their complex lifecycle, invade the red blood cells of their human hosts. In recent years the emergence and spread of malaria parasites with high levels of antimalarial drug resistance has given rise to the very real possibility that within a few years, there will be large parts of the world in which malaria is an untreatable disease. There is therefore an urgent need for new antimalarial drugs. Despite the enormous clinical significance of the malaria parasite, the basic physiology of this organism is not understood. Pathways involved in ion balance, in the uptake of essential nutrients and in the release of potentially toxic waste products all play a crucial role in the survival of the parasite and are potential chemotherapeutic targets. However the properties of these pathways are, as yet, largely unknown. This work will provide fundamental (and pharmacological) information about these pathways. It will thereby open up exciting new possibilities with regard to the chemotherapy of malaria and will provide a rational basis for a strategy in which these pathways might be exploited as antimalarial drug targets.
    Read more Read less
    More information
    Funded Activity

    Understanding Antimalarial Drug Action And Parasite Res Istance

    Funder
    National Health and Medical Research Council
    Funding Amount
    $209,181.00
    More information
    Funded Activity

    Chloroquine Resistance And The Physiology Of The Malaria Parasite S Digestive Vacuole

    Funder
    National Health and Medical Research Council
    Funding Amount
    $287,921.00
    Summary
    Malaria is an infectious disease, caused by a single-celled parasite which invades the red blood cells of its human host. Each year, malaria causes the death of up to 3 million people, mostly children under the age of 5 The parasite has become resistant to most, if not all, of the antimalarial drugs presently available, and there is no vaccine. There is therefore an urgent need to develop new antimalarial drugs, and-or to devise strategies for overcoming the parasite s drug resistance mechanisms .... Malaria is an infectious disease, caused by a single-celled parasite which invades the red blood cells of its human host. Each year, malaria causes the death of up to 3 million people, mostly children under the age of 5 The parasite has become resistant to most, if not all, of the antimalarial drugs presently available, and there is no vaccine. There is therefore an urgent need to develop new antimalarial drugs, and-or to devise strategies for overcoming the parasite s drug resistance mechanisms. Chloroquine was, for many years, the mainstay of antimalarial chemotherapy and was, in many senses, a 'wonder-drug' cheap, safe and effective. However the emergence and spread of parasites that are resistant to chloroquine has meant that the drug is now largely useless as an antimalarial. Chloroquine kills (sensitive) parasite through an effect on the parasite s digestive vacuole an internal acidic compartment in which the parasite breaks down protein taken up from its host red blood cell. This compartment plays a crucial role in the growth and proliferation of the parasite. Yet we understand very little about its basic physiology, and nor do we understand the mechanism by which chloroquine-resistant parasites are able to survive exposure to the drug. The aim of the work proposed here is to gain an increased understanding of some of the mechanisms underlying the physiology of the parasite s digestive vacuole, as well as some of the factors influencing the accumulation of chloroquine within this compartment. The former part of the work may well reveal new antimalarial drug targets. The latter part of the work will increase our understanding of the mechanism of chloroquine resistance, thereby laying the groundwork for strategies by which these mechanisms might be circumvented and chloroquine-related drugs thereby restored to the front-line of our ongoing and increasingly desperate fight against malaria.
    Read more Read less
    More information
    Funded Activity

    The Na+-H+ Exchanger And H+-pumping Pyrophosphatases Of The Malaria Parasite

    Funder
    National Health and Medical Research Council
    Funding Amount
    $664,604.00
    Summary
    Malaria is an infectious disease caused by a single-celled parasite. The disease kills up to 2 million people each year and the parasite is becoming increasingly resistant to available drugs. This work focuses on the mechanisms by which the parasite controls its internal ion concentrations. These mechanisms may be new drug targets, and they may also play a role in antimalarial drug resistance. For both of these reasons it is important that we understand them.
    More information

    Showing 1-10 of 14 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback